[Nosocomial pneumonia: a report of 372 cases]
- PMID: 1286582
[Nosocomial pneumonia: a report of 372 cases]
Abstract
Three hundred seventy-two cases of hospital-acquired pneumonia occurring during a 4-year period were reviewed. It was found that the annual incidence of the pneumonia was 1.44% which ranked first in the incidence of nosocomial infections at this institution. Most of the patients had suffered from primary severe underlying diseases with immunosuppression of different degrees. A variety of factors such as antibiotic and steroid therapy, operation, intensive care, endotracheal intubation, tracheostomy, chemotherapy and radiotherapy predisposed to the acquisition of this pneumonia. Most frequent etiologic agents for hospital-acquired pneumonia were Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans. The overall mortality rate was 25.3%. However, deaths associated with Pseudomonas aeruginosa and Staphylococcus aureus are particularly high, with rates of 70.6% and 66.7% respectively. The incidence, mortality, pathogenesis, diagnosis, treatment and prevention of the disorder were discussed briefly.
Similar articles
-
[Infection pathogen analysis of 2388 patients in an open hematology ward from 1993 to 2004].Zhonghua Yi Xue Za Zhi. 2006 Mar 14;86(10):664-8. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16681921 Chinese.
-
Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy.Infection. 2006 Feb;34(1):9-16. doi: 10.1007/s15010-006-5007-x. Infection. 2006. PMID: 16501896
-
Hospital-Acquired Pneumonia in a Multipurpose Intensive Care Unit: One-Year Prospective Study.Acta Med Port. 2019 Dec 2;32(12):746-753. doi: 10.20344/amp.11607. Epub 2019 Dec 2. Acta Med Port. 2019. PMID: 31851883
-
Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S36-41. doi: 10.1086/653038. Clin Infect Dis. 2010. PMID: 20597669 Review.
-
Epidemiology of healthcare-associated pneumonia (HCAP).Semin Respir Crit Care Med. 2009 Feb;30(1):10-5. doi: 10.1055/s-0028-1119804. Epub 2009 Feb 6. Semin Respir Crit Care Med. 2009. PMID: 19199182 Review.
Cited by
-
Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study.Clinicoecon Outcomes Res. 2014 Oct 17;6:451-61. doi: 10.2147/CEOR.S65900. eCollection 2014. Clinicoecon Outcomes Res. 2014. PMID: 25378939 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical